Selective regulation of IFN-γ and IL-4 co-producing unconventional T cells by purinergic signaling.
Saved in:
| Title: | Selective regulation of IFN-γ and IL-4 co-producing unconventional T cells by purinergic signaling. |
|---|---|
| Authors: | Xu C; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Obers A; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Qin M; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China., Brandli A; Department of Anatomy and Physiology, The University of Melbourne, Melbourne, Australia., Wong J; The Florey Institute of Neuroscience and Mental Health , Melbourne, Australia., Huang X; The Florey Institute of Neuroscience and Mental Health , Melbourne, Australia., Clatch A; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Fayed A; Liver and Intestinal Transplant Unit, Austin Health , Melbourne, Australia.; Department of Surgery, The University of Melbourne, Austin Health, Melbourne, Australia., Starkey G; Liver and Intestinal Transplant Unit, Austin Health , Melbourne, Australia.; Department of Surgery, The University of Melbourne, Austin Health, Melbourne, Australia., D'Costa R; DonateLife Victoria , Carlton, Australia.; Department of Intensive Care Medicine, Melbourne Health, Melbourne, Australia., Gordon CL; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; Department of Infectious Diseases, Austin Health, Melbourne, Australia.; North Eastern Public Health Unit, Austin Health , Melbourne, Australia., Mak JYW; Centre for Chemistry and Drug Discovery, Institute for Molecular Bioscience, University of Queensland , Brisbane, Australia.; ARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, University of Queensland , Brisbane, Australia., Fairlie DP; Centre for Chemistry and Drug Discovery, Institute for Molecular Bioscience, University of Queensland , Brisbane, Australia.; ARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, University of Queensland , Brisbane, Australia., Beattie L; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Mackay LK; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Godfrey DI; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Koay HF; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. |
| Source: | The Journal of experimental medicine [J Exp Med] 2024 Dec 02; Vol. 221 (12). Date of Electronic Publication: 2024 Nov 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
